Windtree Therapeutics - Warrants (25/03/2026) (WINT+) Q4 2021 Earnings

31MarExpected
Q1 2021
Q2 2021
Q3 2021
Q4 2021
-26
-17.17
-8.33
0.5

Details

Expected EPS
-15
Actual EPS
-26
Surprise EPS
-11
Surprise Percent
+73.33%

Description

Windtree Therapeutics - Warrants (25/03/2026) (WINT+) has reported earnings of -26 per share for Q4 2021.

0 Comments

Share your thoughts